Enhertu (trastuzumab deruxtecan) isn't currently listed among the standard approved treatments for stage 4 ovarian cancer. It's worth knowing what treatments are currently recognized for stage 4 ovarian cancer, as there are several options available.
Here's a summary of the main treatment approaches:
- Surgery (debulking) Show Full Answer
Enhertu (trastuzumab deruxtecan) isn't currently listed among the standard approved treatments for stage 4 ovarian cancer. It's worth knowing what treatments are currently recognized for stage 4 ovarian cancer, as there are several options available.
Here's a summary of the main treatment approaches:
- Surgery (debulking): Removes as much of the tumor as possible to help other treatments work better
- Chemotherapy: Usually a combination of carboplatin and paclitaxel, sometimes given before surgery (neoadjuvant) or after (adjuvant)
- Bevacizumab (Avastin): A targeted therapy often combined with chemotherapy that works by cutting off the tumor's blood supply
- PARP inhibitors: Such as olaparib (Lynparza) or rucaparib (Rubraca), which stop cancer cells from repairing their DNA
- Mirvetuximab soravtansine-gynx: A newer FDA-approved targeted therapy for high-grade serous epithelial cancer that overproduces a protein called FR-alpha
- Palliative care: Focused on managing symptoms and improving quality of life
That said, clinical trials are constantly exploring new treatments. It's absolutely worth asking an oncologist whether Enhertu or any other emerging therapies might be available through a clinical trial for your specific situation.
September 7
Join
Your Privacy Choices
